MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2023 International Congress

    Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

    S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To assess whether changes in hippocampal subfield volumes are associated with cognition or CSF β-amyloid 1–42 (Aβ42) levels in Parkinson’s Disease (PD). Background: Hippocampal…
  • 2023 International Congress

    Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

    CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)

    Objective: To obtain common features of Parkinson's disease (PD) with cognitive impairment (CI) in resting-state functional MRI (rs-fMRI) from cross-institution datasets by adopting machine learning.…
  • 2023 International Congress

    Influence of square-stepping exercise on brain activation in older adults with cognitive frailty

    YH. Wang, RY. Wang, YR. Yang (Taipei, Taiwan)

    Objective: To investigate the brain activity induced by square-stepping exercise (SSE), as well as the relationships between brain activity change and SSE performance in older…
  • 2023 International Congress

    Differences in EEG spectral features in Alzheimer’s and Parkinson’s disease with mild cognitive impairment

    M. Ajcevic, M. Catalan, P. Polverino, K. Iscra, G. Mazzon, C. Bertolotti, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to examine changes in brain cortical activity using high-density EEG in subjects with mild cognitive impairment (MCI) due…
  • 2023 International Congress

    Exploring brain mechanisms of identity attribution in presence hallucinations of Parkinsonian origin

    J. Potheegadoo, N. Vehar, F. Bernasconi, C. Stucker, S. Stampacchia, O. Blanke (Geneva, Switzerland)

    Objective: Study cognitive, behavioral correlates of identity of presence hallucinations in Parkinson’s disease. Background: Presence hallucination (PH), the sensation that someone is nearby when no…
  • 2023 International Congress

    Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms

    J. Goldman, H. Peirce, D. Merkitch (Chicago, USA)

    Objective: To examine the experiences of people with Parkinson’s disease (PD) and care partners (CPs) regarding cognitive, mood, behavioral, and sleep issues. Background: Neuropsychiatric symptoms…
  • 2023 International Congress

    Subjective cognitive complaints in patients with progressive supranuclear palsy and corticobasal syndrome

    JS. Lee, JH. Ahn, J. Youn, JW. Cho (Seoul, Republic of Korea)

    Objective: In the present study, we evaluate a prevalence of subjective cognitive complaints (SCC)in patients with progressive supranuclear palsy (PSP) as well as clinical features…
  • 2023 International Congress

    Association between subjective and objective language measures in DBS candidates

    T. Turner, L. Blackett, F. Rodriguez-Porcel (Charleston, USA)

    Objective: Determine if expressive language measures from neuropsychological testing correspond to subjective communication struggles in Deep Brain Stimulation (DBS) candidates. Background: A number of studies…
  • 2023 International Congress

    Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations

    F. Bernasconi, J. Pagonabarraga, H. Bejr-Kasem, S. Martinez-Horta, J. Marín-Lahoz, A. Horta-Barba, J. Kulisevsky, O. Blanke (Geneva, Switzerland)

    Objective: Identify alterations associated with minor hallucinations (MH) and their role in cognitive decline in patients with Parkinson’s disease (PD) by merging electroencephalography (EEG) with…
  • 2023 International Congress

    The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

    C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

    Objective: To develop a cognitive composite measure that is sensitive to decline in executive functioning for use in Parkinson’s disease (PD) clinical trials. Background: The…
  • 1
  • 2
  • 3
  • …
  • 106
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23360 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23972 (not found)
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Insulin dependent diabetes and hand tremor
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley